Advanced search
Publication Cover
Journal of Occupational and Environmental Hygiene Volume 12, 2015 - Issue 2
Submit an article Journal homepage
526
Views
23
CrossRef citations to date
0
Altmetric
Departments

Multicenter Study of Environmental Contamination with Antineoplastic Drugs in 36 Canadian Hospitals: A 2013 Follow-up Study

M. BerruyerPharmacy Department and Pharmacy Practice Research Unit, CHU Sainte-Justine, Montreal, Québec, Canada
,
C. TanguayPharmacy Department and Pharmacy Practice Research Unit, CHU Sainte-Justine, Montreal, Québec, Canada
,
N. J. CaronCentre de toxicologie du Québec, Institut national de santé publique du Québec, Québec, Québec, Canada
,
M. LefebvreCentre de toxicologie du Québec, Institut national de santé publique du Québec, Québec, Québec, Canada
&
J. F. BussièresPharmacy Department and Pharmacy Practice Research Unit, CHU Sainte-Justine, Montreal, Québec, Canada;Faculty of Pharmacy, University of Montreal, Montreal, Québec, CanadaCorrespondence[email protected]
Pages 87-94 | Published online: 31 Dec 2014

REFERENCES

  • National Institute for Occupational Safety and Health (NIOSH): “Preventing Occupational Exposure to Antineoplastic and Other Hazardous Drugs in health Care Settings.” Cincinnati, Ohio: NIOSH, 2004. Available at http://www.cdc.gov/niosh/docs/2004-165/. (accessed Sept. 21, 2012).
  • Hedmer, M., and G. Wohlfart: Hygienic guidance values for wipe sampling of antineoplastic drugs in Swedish hospitals. J. Environ. Monit. 14:1968–1975 (2012).
  • Merger, D., C. Tanguay, E. Langlois, M. Lefebvre, and J.F. Bussières: Multicenter study of environmental contamination with antineoplastic drugs in 33 Canadian hospitals. Int. Arch. Occup. Environ. Health 87(3):307–313 (2014).
  • El-Ebiary, A.A., A.A. Abuelfadl, and N.I. Sarhan: Evaluation of genotoxicity induced by exposure to antineoplastic drugs in lymphocytes of oncology nurses and pharmacists. J. Appl. Toxicol. 33(3):196–201 (2013).
  • National Institute for Occupational Safety and Health (NIOSH): “Medical Surveillance for Health Care Workers Exposed to Hazardous Drugs.” Cincinnati, Ohio: NIOSH, 2012. Available at http://www.cdc.gov/niosh/docs/wp-solutions/2013-103/pdfs/2013-103.pdf (accessed Oct. 15, 2013).
  • Schierl, R., A. Bohlandt, and D. Nowak: Guidance values for surface monitoring of antineoplastic drugs in German pharmacies. Ann. Occup. Hyg. 53(7):703–711 (2009).
  • Cocker, J., Jones, J. Morton, and H.J. Mason: Biomonitoring at the UK Health and Safety Laboratory. Int. J. Hyg. Environ. Health 210(3–4):383–386 (2007).
  • Association paritaire pour la santé et la sécurité au travail, secteur des affaires: sociales: “Prevention Guide - Safe Handling of Hazardous Drugs,” 2008. Available at http://www.asstsas.qc.ca/publications/publicationsspecialisees/guides-de-prevention/prevention-guide-safe-handlingof-hazardous-drugs.html (accessed Sept. 21, 2012).
  • Bussières, J.F., C. Tanguay, K. Touzin, E. Langlois, and M. Lefebvre: Environmental contamination with hazardous drugs in Quebec hospitals. Can. J. Hosp. Pharm. 65(6):428–435 (2012).
  • Larson, R.R., M.B. Khazaeli, and H.K. Dillon: Monitoring method for surface contamination caused by selected antineoplastic agents. Am. J. Health Syst. Pharm. 59(3):270–277 (2002).
  • Official Journal of the European Union: “Commission Directive 2009/90/CE of 31 July 2009. Article 5: Calculation of Mean Values,” 2009. Available at http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:2009:201:0036:0038:EN:PDF. (accessed Oct 4, 2012).
  • Hornung, R.W., and L.D. Reed: Estimation of average concentration in the presence of nondetectable values. Appl. Occup. Environ. Hyg. 5(1):46–51 (1990).
  • Sottani, C., B. Porro, M. Comelli, M. Imbriani, and C. Minoia: An analysis to study trends in occupational exposure to antineoplastic drugs among health care workers. J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci. 878(27):2593–2605 (2010).
  • Sessink, P.J., J. Trahan, and W. Coyne: Reduction in surface contamination with cyclophosphamide in 30 US hospital pharmacies following implementation of a closed-system drug transfer device. Hosp. Pharm. 48(3):204–212 (2013).
  • Yoshida, J., S. Koda, S. Nishida, H. Nakano, G. Tei, and S. Kumagai: Association between occupational exposure and control measures for antineoplastic drugs in a pharmacy of a hospital. Ann. Occup. Hyg. 57(2):251–260 (2012).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.